Understanding how regeneration stops in tissues
Molecular Mechanisms of Regeneration Termination
This study is looking at how our bodies know when to stop healing damaged tissues, using fruit flies to learn more about the signals that tell stem cells to take a break and keep everything balanced, which is important for preventing issues like tumors.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Minnesota NIH-funded |
| Lab location | 1 site (Minneapolis, United States) |
| Project ID | NIH-11002294 on NIH RePORTER |
What this research studies
This research investigates the molecular mechanisms that control when regeneration in damaged tissues should stop. By using the Drosophila midgut intestinal stem cell as a model, the study aims to uncover how tissues sense the need to terminate stem cell activity and maintain the integrity of the extracellular matrix. The research employs advanced techniques like RNA sequencing to identify genes and pathways involved in this process, which is crucial for preventing uncontrolled cell growth and potential tumor formation.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions that involve tissue regeneration or repair, such as those recovering from injuries or surgeries.
Not a fit: Patients with stable, non-regenerative conditions or those not undergoing any tissue repair processes may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved therapies for regenerative medicine and cancer prevention by better understanding how to control stem cell activity.
How similar studies have performed: Other research has shown success in using model organisms like Drosophila to understand complex biological processes, indicating that this approach has potential for valuable insights.
Where this research is happening
Minneapolis, United States
- University of Minnesota — Minneapolis, United States (Active)
Researchers
- Principal investigator: Nakato, Hiroshi — University of Minnesota
- Study coordinator: Nakato, Hiroshi
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.